dasatinib
A Bcr-Abl tyrosine kinase inhibitor, Dasatinib is an anti cancer drug. It is administered orally and used for the treatment of prostrate cancer and many other cancers. It is a Src family tyrosine kinase inhibitor used for treating leukemia.. Reference standards of Dasatinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Dasatinib β-D-Glucuronide
[catalogue_number] => PA 04 07590
[category_ids] => ,95,78,70,82,
[chemical_name] =>
[weight] => 664.13
[form] => C28H34ClN7O8S
[cas] => NA
[pslug] => dasatinib-beta-d-glucuronide-pa0407590
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Dasatinib β-D-Glucuronide
Catalogue No.:PA 04 07590
Molecular Formula : C28H34ClN7O8S
Molecular Weight : 664.13